RxSight Inc [RXST] stock is trading at $51.25, up 0.29%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RXST shares have gain 1.99% over the last week, with a monthly amount glided 4.81%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on October 29, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $72. Previously, Needham reaffirmed its Buy rating on August 20, 2024, and elevated its price target to $66. On August 06, 2024, Needham reiterated its Buy rating and revised its price target to $54 on the stock. BTIG Research reiterated its Buy rating and increased its price target to $72 on May 07, 2024. Wells Fargo upgraded its rating to a Overweight and raised its price target to $42 on December 13, 2023. Stifel started tracking with a Buy rating for this stock on December 12, 2023, and assigned it a price target of $40. In a note dated December 04, 2023, Morgan Stanley initiated an Overweight rating and provided a target price of $36 on this stock.
RxSight Inc [RXST] stock has fluctuated between $22.60 and $66.54 over the past year. Currently, Wall Street analysts expect the stock to reach $70.11 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $51.25 at the most recent close of the market. An investor can expect a potential return of 36.8% based on the average RXST price forecast.
Analyzing the RXST fundamentals
RxSight Inc [NASDAQ:RXST] reported sales of 115.18M for the trailing twelve months, which represents a growth of 67.65%. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -0.34%, Pretax Profit Margin comes in at -0.3%, and Net Profit Margin reading is -0.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.19 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 50.28 points at the first support level, and at 49.31 for the second support level. However, for the 1st resistance point, the stock is sitting at 52.61, and for the 2nd resistance point, it is at 53.97.
Ratios To Look Out For
For context, RxSight Inc’s Current Ratio is 14.33. As well, the Quick Ratio is 13.34, while the Cash Ratio is 1.25. Considering the valuation of this stock, the price to sales ratio is 17.81, the price to book ratio is 7.38.
Transactions by insiders
Recent insider trading involved ILYA GOLDSHLEGER, Officer, that happened on Nov 04 ’24 when 3100.0 shares were purchased., Goldshleger Ilya completed a deal on Oct 30 ’24 to sell 3105.0 shares. Meanwhile, Officer LYA GOLDSHLEGER bought 3105.0 shares on Oct 30 ’24.
